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Abstract 
Large bone defects resulting from musculoskeletal tumours, infections, or trauma are often unable to heal sponta-
neously. The challenge for surgeons is to avoid amputation, and provide the best functional outcomes. Allograft, 
vascularized fibular or iliac graft, hybrid graft, extracorporeal devitalized autograft, distraction osteogenesis, induced-
membrane technique, and segmental prostheses are the most common surgical strategies to manage large bone 
defects. Given its optimal osteogenesis, osteoinduction, osteoconduction, and histocompatibility properties, along 
with the lower the risk of immunological rejection, autologous graft represents the most common used strategy for 
reconstruction of bone defects. However, the choice of the best surgical technique is still debated, and no consensus 
has been reached. The present study investigated the current reconstructive strategies for large bone defect after 
trauma, infections, or tumour excision, discussed advantages and disadvantages of each technique, debated available 
techniques and materials, and evaluated complications and new perspectives.
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Introduction
Large bone defects resulting from musculoskeletal 
tumours, infections or trauma represent a tissue deficit 
unable to heal spontaneously even with adequate care 
and surgical stabilization [1, 2]. Surgical management 
aims to reconstruct the defect, avoiding amputation and 
providing acceptable functional outcomes [3]. Recon-
struction can involve massive intercalary replacement 
when the whole diaphysis is replaced [4], or joint com-
ponents, in association, if necessary, with prosthetic ele-
ments [5, 6]. Intercalary reconstructions showed better 
functional outcomes compared to other limb salvage pro-
cedures from lower morbidity of the adjacent joints [7]. 
Reconstructive management for large bone defects can 
involve autograft, allograft and non-biological materials 
[8]. Autografts such as vascularized fibular graft [9] or 
vascularized iliac bone graft [10, 11] are considered the 
gold standard for reconstruction of post-traumatic bone 
defects with non-union or malunion, given their prop-
erties of osteogenesis, osteoinduction, osteoconduction, 
and histocompatibility, leading to a low risk of immu-
nological rejection [12–14]. Disadvantages are the lim-
ited amount of bone graft available, infection, prolonged 
wound drainage, and reoperation of the donor site [15, 
16]. Another type of autograft, after bone tumour resec-
tion, consists in the re-use of the excised bone segment. 
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by pasteurization, autoclaving, gamma irradiation or 
cryotherapy, resulting in reduction of graft osteogenic-
ity and osteoinductivity [17–19]. Allografts represent a 
valid alternative to autografts, and are commonly used 
after bone tumour resection [20]. The main advantages 
of these grafts are their relative abundance, which allows 
reconstruction even after massive bone defect, and the 
absence of morbidity of the donor site [21]. The disad-
vantages, on the other hand, are immunological rejection 
and the risk of transmissive diseases, such as HIV and 
Hepatitis C [22–24]. However, these latter are reduced by 
modern screening methods [21, 23]. Bone cement spac-
ers and induced-membrane technique is another alterna-
tive available for the reconstruction of bone defects [25, 
26]. This technique is used to manage infected or unin-
fected bone defects [27, 28]. However, these techniques 
exhibit poor bone integration and slow remodelling, 
which make them more suitable for the reconstruction 
of upper limb defects, as mechanical failure is a frequent 
complication in the lower limb [4]. The main non-bio-
logical materials are segmental endoprosthesis [4, 21]. 
Segmental prostheses have several advantages, such as 
immediate stability, rapid rehabilitation, and early weight 
bearing [24]. The disadvantages, on the other hand, are 
infections, mechanical loosening, mechanical wear, 
and prosthetic and periprosthetic fracture [21, 29]. The 
choice of the best surgical technique is still debated, and 
no consensus has been reached. The present study inves-
tigated current reconstructive strategies for large bone 
defect after trauma, infections, or tumour excision, dis-
cussed advantages and disadvantages of each technique, 
debated available techniques and materials, and evalu-
ated complications and new perspectives.
Reconstruction using biological materials
Biological reconstructions can be managed through via-
ble or non-viable bone material [4]. Viable bone mate-
rial was considered the gold standard for reconstruction 
of post-traumatic bone defects from non-union or mal-
union, given its properties of osteogenesis, osteoinduc-
tion, osteoconduction, and histocompatibility, given its 
low risk of immunological rejection and a high rate of 
neoformation of bone [12, 13, 30]. Vascularized fibu-
lar graft, vascularized iliac bone graft, bone lengthening 
utilizing external fixation, and the induced-membrane 
technique are all examples of reconstruction techniques 
using viable bone [9–11]. Allograft, a biological recon-
struction technique through non-viable bone, is used in 
reconstruction after resection of a bone tumour [6, 20, 
21]. The combined reconstruction with a vascularized 
fibula and an allograft has the advantages of both previ-
ously described techniques [31]. Furthermore, among the 
reconstruction techniques which use non-viable bone 
material, the re-use of resected tumour bone can also be 
included [32]. For this purpose, the bone segment must 
be processed by pasteurization, gamma irradiation, or 
cryotherapy [17–19].
Vascularized fibular graft
Vascularized fibular grafts are commonly used to recon-
struct bone defects larger than 6  cm, after infection, 
tumour excision, and trauma [33], often in combination 
with soft tissue defects [34]. Three different options of 
vascularized fibular graft have been developed: single 
vascularized fibular graft, double-barrel technique, and 
combined vascularized fibula and allograft reconstruc-
tion [4, 35, 36]. In adult patients, a fibular graft up to 
25–26 cm can be harvested [21, 37]. The proximal fibula 
and the lateral malleolus should be spared to maintain 
knee and ankle joint stability, protect the common pero-
neal nerve, and preserve weight-bearing capacity [9, 21, 
33, 35, 37]. A classical single vascularized fibular graft 
(Fig. 1), having a reduced cross section, could be at risk of 
stress fractures if used in the lower limbs [34, 38, 39]. To 
prevent them, techniques such as the double-barrel tech-
nique and the combined vascularized fibula and allograft 
reconstruction have been developed [38]. Indications 




Fig. 1 Single vascularized fibular graft with vascular pedicle. A 
Proximal osteotomy; B fibular graft with peroneal artery, periosteal 
branches, and vascular pedicle; C distal osteotomy
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reconstruction, tibial defect, bone defect in paediatric 
patients and in general all areas under lighter stress load 
[4, 40]. In the double-barrel technique, the fibular graft, 
thanks to its dual vascularization and adequate blood 
supply, can be transversely osteotomized to produce two 
pieces [38, 41]. This procedure, which allows the graft to 
double its cross section and increase its weight-bearing 
capacity [38, 41, 42], is particularly suitable for recon-
struction of the femur and pelvis [38, 42]. However, the 
bone defect for which this technique can be used must 
not exceed 13 cm in length [41]. Complications such as 
infections, fixation failure and graft fracture have been 
reported [40, 43–45], but the rate of union was 82% at 
2 years and 97% at 5 years. Union was achieved without 
further surgery in 70% of patients at a mean of 10 months 
post-operatively. Major complications such as deep soft-
tissue infection, thrombosis of the pedicle, stress fracture 
not associated with fixation failure, compartment syn-
drome, and vascular injury have been reported. Liu et al. 
[46], in a long-term follow-up of fibular graft, reported 
union rates of 100% and mean union time of 21.3 weeks.
Combined vascularized fibula and allograft reconstruction 
or hybrid graft
First described by Capanna et al. in the early 1990s [47], 
this technique consists of combining the advantages pro-
vided by the mechanical strength of allografts and the 
advantages of the biological properties of the autograft 
[31, 48]. The allograft mainly provides bone support and 
early stability, while the vascularized fibula facilitates the 
integration between host and allograft, and has the ability 
to rapidly consolidate [31, 49, 50]. This hybrid graft can 
be assembled by the intramedullary or the onlay tech-
nique [50, 51]. The intramedullary technique consists 
of inserting the vascularized fibula inside the allograft 
(Fig. 2). For this purpose, the anterolateral cortex of the 
allograft is opened and the medullary canal reamed for a 
length suitable to accommodate the fibula [50–52]. When 
the fibula is inserted into the autograft, particular atten-
tion should be paid not to damage the vascular pedicle 
[52]. This technique is indicated in massive intercalary 
reconstruction of femur and tibia, especially in patients 
with long life expectancy and high physical demands 
[33, 50, 52]. A common complication associated with 
this technique is thrombosis of the anastomosed vessels, 
which can lead to failure of the graft [48]. Uncontrolled 
bleeding, stress fractures, delayed or failed bone consoli-
dation, delayed bone growth, persistence of deformity, 
infections, and compartment syndrome are complica-
tions associated with the technique [9, 33, 50, 53, 54]. The 
overall limb salvage rate was 94%, hybrid graft fractures 
occurred in 23%, and infection in 6% [54]. The median 
time to full weight-bearing with a removable orthosis 
was 3.5 months, consolidation of the proximal anastomo-
sis was achieved over a median of 6 months, four of the 
seven grafts fractured in the distal anastomosis between 
6 and 14  months after surgery. After reoperation, con-
solidation of the distal anastomosis was observed after 
2.8 months [50].
Iliac crest bone graft
Iliac crest bone grafting is another commonly used strat-
egy to reconstruct bone defects secondary to infection, 
tumour excision and fractures [55, 56]. Iliac crest bone 
graft presents all the advantages of autografts: osteogen-
esis, osteoinduction, osteoconduction, and histocompat-
ibility [57–60]. The bone graft can be harvested from the 
anterior or the posterior iliac crest [61]. The anterior iliac 
crest is harvested about 4–5  cm posterior to the ante-
rior superior iliac spine [62, 63], with a length that does 
not exceed 30  mm to prevent iliac crest stress fracture 
[64, 65]. Many techniques to harvest the anterior iliac 
crest have been developed, such as trapdoor technique, 
tricortical technique [62, 63], segmental bicortical tech-
nique, iliac crest-splitting technique, trephine technique, 
and acetabular reamer technique [63]. These procedures 
all access the inner or outer table of the ileum to har-
vest the cortico-cancellous graft or pure cancellous graft 
[63]. Accessing the posterior iliac crest allows to harvest 
a segment up to 30 cm long, and it is therefore indicated 
when a large graft volume is required. The trapdoor tech-
nique is particularly effective to obtain a cancellous graft 
from the posterior ileum [63]. The traditional harvesting 
technique to obtain an iliac graft may be associated with 
several complications. The complications that occur after 
Fig. 2 Intramedullary hybrid graft: a vascularized fibular autograft 
inserted into medullary canal of a cadaveric femoral allograft
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the harvest of the autogenous iliac crest can be divided 
into major and minor, which occur, respectively, in 10% 
and 5.8% of patients [10]. Major complications are vascu-
lar injury, nerve injury, donor defect hernias, deep infec-
tion, deep hematomas, and iliac wing fractures. Minor 
complications are superficial infection, minor hemato-
mas, and superficial seromas. Calori et al. [66] compared 
complications related to the donor site using traditional 
iliac crest bone graft harvest and the reamer irrigator 
aspirator (RIA) [60, 67, 68] technique. They noted that 
14.28% of patients with iliac harvesting reported pain at 
the donor site, while no pain was reported by patients 
who underwent RIA. Infection at the donor site did not 
occur in any patient undergoing RIA, while 14.28% of 
patients undergoing iliac harvesting presented an infec-
tion. Finally, no patient operated with RIA presented a 
fracture at the donor site, while 2.8% of the patients who 
underwent iliac harvesting presented an anterior supe-
rior iliac spine fracture.
Reconstruction by distraction osteogenesis
Described by Ilizarov in the 1950s [69], distraction oste-
ogenesis has been applied to correct bone deformities, 
congenital musculoskeletal pathologies, manage bone 
defects following trauma, infections, and in cancer sur-
gery [70–72]. In the past decades, distraction osteogen-
esis was seldom performed, as it was believed to cause 
tumour recurrence [21, 70]. Indeed, distraction osteo-
genesis can only be performed when full tumour resec-
tion is achieved [21, 70, 73]. Three different procedures 
for bone reconstruction after tumour resection have been 
described: segmental transport, shortening–distraction 
with an external fixation (Fig. 3), and shortening–distrac-
tion with an intramedullary nail to shorten the time of 
use of external fixation. Given the long time required for 
external fixation, this technique is only useful if the defect 
is between 4 and 6  cm [70]. Distraction begins gradu-
ally 7–14  days after surgery, with a maximum amount 
of 1 mm of bone distraction per day. Each millimetre of 
bone distraction requires approximately 2  days to con-
solidate [4, 21, 70]. Long-term external fixation, in addi-
tion to being uncomfortable for the patient, increases the 
risk of superficial and deep infections, loosening of the 
pins, and rotational and axial deviation [21, 70, 72, 74]. 
This technique regenerates living viable bone tissue to 
repair the bone defect [21, 75]. Schep et al. [76] reported 
a mean of 1.5-month distraction osteogenesis to achieve 
a growth of 1 cm for post-traumatic lower limb defects, 
and a rate of pin tract infections of 53%. Demiralp et al. 
[75] reported a mean time of 28  days per cm for inter-
calary bone defect reconstruction following bone tumour 
resection, and a rate of 61.5% of pin tract infections.
Bone cement spacer and induced‑membrane technique
The induced-membrane technique or Masquelet tech-
nique is used for bone defect reconstruction after infec-
tion, tumour excision and fractures [4, 25, 77]. This 
technique is performed in two steps (Fig.  4). The first 
phase consists of debridement, followed by the insertion 
of a polymethylmethacrylate spacer into the bone defect 
[78–80]. Polymethylmethacrylate causes a mild foreign-
body inflammatory response which induces the devel-
opment of a thick pseudo-synovial membrane which 
acts as a newly performed periosteum [78, 79, 81, 82]. 
This pseudomembrane is highly vascularized and rich in 
growth factors [78, 79]. The second phase, which begins 
after 6–8  weeks, involves opening the membrane and 
removing the spacer, replacing it with a bone graft [4, 25, 
79, 83]. The spacer is a local antibiotic carrier, it reduces 
dead space, and, for this reason, it is especially indicated 
A B C D
Fig. 3 Shortening–distraction with an external fixation. A 
Osteofibrous dysplasia; B tumour resection, external fixation 
application, and osteotomy for bone transport; C bone transport 
procedure; D docking of bone transport and bone union
A B C D E F
STEP 1 STEP 2
Fig. 4 Bone cement spacer and induced-membrane technique 
steps. Step 1 includes debridement, fixation, cement spacer 
implantation and membrane formations (A traumatized, infected 
or cancerous tissues; B debridement; C spacer implantation and 
membrane formation); Step 2 involves in space removal preserving 
the membrane and the implantation of bone graft material (D spacer 
removal with membrane preservation; E implantation of bone graft 
material; F graft remodelling and bone regeneration)
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in the management of infected bone defects [25, 83]. 
However, this technique showed slow bone integration 
and a fair amount of graft remodelling [4, 84]. It is com-
monly preferred for upper limb defect reconstruction, 
given its high failure rate in lower limb reconstruction 
from mechanical failure [4]. Lemos Azi et  al. [25] con-
ducted a study on the induced-membrane technique and 
demonstrated that infection occurred in 68% of patients, 
and soft tissue reconstruction was required in 32% of 
patients. Bone union was achieved in 91% of patients 
within a mean time of 8.5 months.
Extracorporeal devitalized autograft reconstructions
Recycling of the tumour-bearing bone segment is an 
alternative to allograft to repair bone defects follow-
ing cancer surgery [85]. Several techniques have been 
developed to remove tumour cells from the resected 
bone fragment and make it reimplantable, including irra-
diation, pasteurization, and cryotherapy [18]. A most 
important advantage is that the processed autograft 
has the exact shape of the bone defect. This is particu-
larly suitable for reconstructions in anatomically difficult 
tumour sites [86]. Other advantages are a low immuno-
genic response, absence of disease transmission, analler-
gicity, the no need for a bone bank, and the possibility of 
overcoming cultural objections to allograft found in some 
countries and cultures. Disadvantages include the risk of 
infection, fracture, bone resorption, graft necrosis, and 
delayed union or non-union [4, 21, 86].
Extracorporeal irradiated autograft
Described by Spira and Lubin in 1968 [87], this technique 
consists of extracorporeal irradiation with reimplanta-
tion of a tumour-bearing bone [88, 89]. The first step is 
to remove the tumour mass with an appropriate margin, 
along with its surrounding soft tissues [4, 90]. Tendons 
and ligaments are preserved to be reused after irradia-
tion [8, 89]. Irradiation consists of 60–70 Gy in a single 
dose [88, 90]. A limitation of this procedure is that the 
irradiated bone fragments have no blood supply and this 
can lead to infections, fractures, non-union, and bone 
re-absorption [90, 91]. To avoid this problem, a vascu-
larized bone graft can be associated with the irradiated 
bone fragment, improving reconstruction and increasing 
vascularization [4, 89, 90]. Oike et al. [89] reported that 
there were no recurrences in the irradiated autograft, 
and 88.9% survived. Non-union occurred in 33.3%, deep 
infections in 14.8%, and subchondral bone collapse was 
observed in 14.8%. Mihara et  al. [90] reported that vas-
cularized bone grafting was successful and survived in 
93.3% of patients, with 85.7% of these patients achieving 
complete bone union at an average of 10.8 months (range 
5–24 months).
Extracorporeal pasteurized autograft
Pasteurization consists in subjecting the tumour-bear-
ing bone to a temperature of about 65 °C for 30–60 min, 
thus killing the tumour cells, without altering the oste-
oinductivity and mechanical resistance of the graft 
[92–94]. After extracorporeal pasteurization, the treated 
bone is relocated to its native site and fixed with plates 
and screws [95]. In a comparative study, among the dif-
ferent methods of extracorporeal devitalization of the 
autograft, pasteurization produced better formation of 
callus and better preservation of osteocytes and bone 
marrow cellularity [17]. The 5, 10, and 20-year survival 
rates of pasteurized bones, calculated using the Kaplan–
Meier method, were 73%, 59%, and 40%, respectively 
[93]. Unfortunately, 38% of the extracorporeal pasteur-
ized autografts were removed because of serious com-
plications. The major complications are infection in 13% 
of patients, non-union in 7%, fracture of the graft in 6%, 
failure of fixation in 5%, resorption of the graft in 5%, and 
local recurrence in 4% [93].
Extracorporeal frozen autograft
The freezing technique uses liquid nitrogen with tem-
peratures to –166  °C to destroy cancer cells [96]. The 
freezing technique induces ice crystal formation and cell 
dehydration [97]. Furthermore, freezing can also cause 
thrombosis of the microcirculation, inducing ischaemic 
necrosis of the tumour [4, 96, 98]. The technique involves 
three steps: the bone fragment is immersed for 20 min, 
thawed for 15 min at room temperature, and rinsed with 
distilled water for 10–15  min [4, 9, 99, 100]. There are 
two different procedures to manage the affected bone 
segment: free freezing and pedicle freezing technique 
[99] (Fig.  5). The free freezing technique involves two 
osteotomies [101] and soft tissue removal by immer-
sion of neoplastic bone in liquid nitrogen [99, 100]. The 
pedicle freezing technique requires a single osteotomy 
PEDICLE FREEZING
FREE FREEZING
Fig. 5 Pedicle freezing method and the free freezing method
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or joint dislocation on the proximal side of the tumour-
bearing bone [102]. After the osteotomy or joint disloca-
tion, the bone is rotated and placed in a container filled 
with liquid nitrogen [99, 102]. Cryotherapy procedures 
have a number of advantages for the bone, as it retains 
good osteoinduction and osteoconduction properties, 
biomechanical strength, with no risk of disease transmis-
sion and less immunological reaction. Moreover, freezing 
requires less equipment than other recycling techniques 
[4, 96, 100]. Zekry et al. [99] reported that 5- and 10-year 
survival rates of frozen autografts were 91.2%, and bone 
union rate was 97%, but fractures occurred in 17.6% of 
patients, with local recurrence of disease from surround-
ing soft tissue in 11.8% of patients. Lu et al. [103] com-
pared the frozen autograft with the Capanna’s technique, 
with no differences in the two operative procedures in 
terms of resection length, surgery duration, and blood 
loss. The mean union time for the frozen autograft was 
8.4  months, significantly shorter than the Capanna’s 
method, which had a mean union time of 14.1  months. 
There are also differences between the two groups in 
terms of complications: infection and delayed union were 
observed in 6.7% and 13.3%, respectively, in the Capan-
na’s group, while no such complications were observed in 
the patients treated with frozen autograft.
Reconstruction using non‑biological materials
Segmental prosthesis
Segmental prostheses (Fig. 6) are an alternative for inter-
calary reconstructions [4]. They allow immediate stabil-
ity, rapid rehabilitation, and early weight bearing [24, 
104]. Common complications are infections, mechanical 
loosening, and mechanical wear [24].
The high risk of prosthetic and periprosthetic frac-
ture has made this technique preferred in patients with 
limited life expectancy from myeloma, lymphoma, or 
metastatic bone cancer [21, 24, 104]. Therefore, elderly 
patients or patients with a limited life expectancy, in 
whom immediate restoration of function and stability is 
more important than durability, are the best candidates 
for this technique [4, 24]. Henderson et al. [105] reported 
a segmental prosthesis failure rate of 24.5%, of which 49% 
were mechanical and 51% non-mechanical. Five failure 
modes were identified: the most common was infection, 
which occurred in 34% of patients, then failures from 
soft tissue problems around the implant, which were 
observed in 12% of patients, aseptic loosening in 19%, 
structural failures in 17%, and failure from tumour pro-
gression in 17%.
Conclusions
The management of large bone defects remains a chal-
lenge. The choice of technique is still debated, and con-
sensus is lacking. Several techniques are available to 
manage bone defects; however, the lack of quantitative 
data, along with the limited quality evidence, does not 
allow to infer solid conclusions. Further investigations 
are necessary to provide quantitative data on the rates of 
complication and reoperation.
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Fig. 6 Illustration showing a large bone defect after bone tumour 
resection and reconstruction with a segmental prosthesis
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